Sonja Zweegman

PROF.DR., (Principal Investigator)

1993 …2019
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1993 2019

89Zr-immuno-PET: Towards a clinical tool to guide antibody-based therapy in cancer

Jauw, YWS., 2019, 230 p.

Research output: ThesisResearch VU University Amsterdam, graduation VU University AmsterdamAcademic

Open Access

89 Zr-immuno-PET: towards a non-invasive clinical tool to measure target engagement of therapeutic antibodies in-vivo

Jauw, Y., o'Donoghue, J., Zijlstra, J., Hoekstra, O., Menke-van der Houven van Oordt, C. W., Morschhauser, F., Carrasquillo, J., Zweegman, S., Pandit-Taskar, N., Lammertsma, A., van Dongen, G., Boellaard, R., Weber, W. & Huisman, M., Dec 2019, In : Journal of Nuclear Medicine. 60, 12, p. 1825-1832

Research output: Contribution to journalArticleAcademicpeer-review

BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease

Atiq, F., Fijnvandraat, K., van Galen, K. P. M., Laros-van Gorkom, B. A. P., Meijer, K., de Meris, J., Coppens, M., Mauser-Bunschoten, E. P., Cnossen, M. H., van der Bom, J. G., Eikenboom, J., Leebeek, F. W. G. & WiN study group, 1 Aug 2019, In : American Journal of Hematology. 94, 8, p. E201-E205

Research output: Contribution to journalLetterAcademicpeer-review

Open Access

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

Moreau, P., Attal, M., Hulin, C., Arnulf, B., Belhadj, K., Benboubker, L., Béné, M. C., Broijl, A., Caillon, H. L., Caillot, D., Corre, J., Delforge, M., Dejoie, T., Doyen, C., Facon, T., Sonntag, C. C., Fontan, J., Garderet, L., Jie, K-S., Karlin, L. & 38 othersKuhnowski, F., Lambert, J. R., Leleu, X., Lenain, P., Macro, M., Mathiot, C., Orsini-Piocelle, F., Perrot, A., Stoppa, A-M., van de Donk, N. W. CJ., Wuilleme, S., Zweegman, S., Kolb, B., Touzeau, C., Roussel, M., Tiab, M., Marolleau, J-P., Meuleman, N., Vekemans, M-C., Westerman, M., Klein, S. K., Levin, M-D., Fermand, J. P., Escoffre-Barbe, M., Eveillard, J-R., Garidi, R., Ahmadi, T., Zhuang, S., Chiu, C., Pei, L., de Boer, C., Smith, E., Deraedt, W., Kampfenkel, T., Schecter, J., Vermeulen, J., Avet-Loiseau, H. & Sonneveld, P., 6 Jul 2019, In : The Lancet. 394, 10192, p. 29-38

Research output: Contribution to journalArticleAcademicpeer-review

Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis: Results of the multicenter HOVON 104 trial

Minnema, M. C., Nasserinejad, K., Hazenberg, B., Hegenbart, U., Vlummens, P., Ypma, P. F., Kröger, N., Wu, K. L., Kersten, M. J., Schaafsma, M. R., Croockewit, S., de Waal, E., Zweegman, S., Tick, L., Broijl, A., Koene, H., Bos, G., Sonneveld, P. & Schönland, S., 2019, In : Haematologica. 104, 11, p. 2274-2282

Research output: Contribution to journalReview articleAcademicpeer-review

Open Access